Pew Provides Feedback on Reducing Drug Costs in Louisiana

Comments focus on how the state can lower spending on hepatitis C, HIV treatments for incarcerated people

Speeches and Testimony Read time:
Projects: Drug Spending Research Initiative
Pew Provides Feedback on Reducing Drug Costs in Louisiana

The Pew Charitable Trusts’ drug spending research initiative submitted comments Aug. 23 to the Louisiana Department of Health on alternative payment models that could help the state provide hepatitis C treatment to its Medicaid, uninsured, and correctional populations.

Pew’s comments focus on how Louisiana could access discounted pricing for hepatitis C drugs for people in these groups and how the state could leverage negotiations for these drugs to also lower treatment costs for HIV.

Downloads Pew Letter on Reducing Drug Costs in Louisiana (PDF)
Downloads Pew Letter on Reducing Drug Costs in Louisiana (PDF)
America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
RELATED
Topics
U.S. Policy Health Care
Projects
Drug Spending Research Initiative
Places
Louisiana

ADDITIONAL RESOURCES

A long and wide wooden pier extends into a large body of water from a shoreline with a mix of low-rise buildings, houses, and trees. Two people are walking on the pier in the distance. Two other piers are visible in the background, as is a faraway mountain.

Article

November 28, 2023 WA Takes New Approach to Help Locals Boost Climate Resilience
An adult and a child huddle in front of a laptop computer, their faces lit by the screen, with a room and bright windows behind them.

Article

November 27, 2023 Researchers Share How State Grants Boost Broadband Access
A river with trees in the background during a sunset.

Article

November 20, 2023 Alaska Tribes Urge U.S. to Protect Critical Lands and Waters

MORE FROM PEW

A person wearing a helmet and harness climbs a ladder on a metallic wind turbine tower. How States Are Advancing Clean Energy
Six workers secure a large blue tarp on the roof of a two-story condominium under a cloudless blue sky. In the foreground is a badly damaged black SUV, along with large branches and pieces of homes—evidence that a strong storm recently struck. Disaster Resilience Efforts Vary Widely Among States
A large blue-and-white vessel, with some visible rust and other signs of wear, sits in a dark blue ocean at a port dock, set against a bright blue sky with fluffy white clouds. The vessel has many booms for nets and has a yellow raft attached to the side Proposal Would Weaken Oversight of $13 Billion Fishery
Four identical long, blue, rectangular flags, each with a white United Nations logo and each on its own flagpole, fly in front of a modern conference building. The image is taken from the ground looking up, so only the rook and top couple of floors of the building are visible, in front of a stark blue cloudless sky. U.N. Climate Talks Offer Promise, but Time Is Short
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics
Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.